Madde Kullanım Bozukluklarında Prekonsepsiyonel Bakım
References
Köroğlu E. Mental Bozuklukların Tanısal ve İstatistiksel El Kitabı (DSM-5). 1. bs. 2015.
Crummy EA, O’Neal TJ, Baskin BM, Ferguson SM. One Is Not Enough: Understanding and Modeling Polysubstance Use. Front Neurosci. 2020; 16(14): 569.
U.S. Department of Health and Human Services. Addiction and Substance Misuse Reports and Publications [Internet]. 2023 Erişim adresi: https://www.hhs.gov/surgeongeneral/reports-and-publications/addiction-and-substance-misuse/index.html Erişim tarihi: 02.05.2024.
Vafaie N, Kober H. Association of Drug Cues and Craving With Drug Use and Relapse: A Systematic Review and Meta-analysis. JAMA Psychiatry. 2022; 79(7): 641-650.
Compton WM, Valentino RJ, DuPont RL. Polysubstance use in the U.S. opioid crisis. Mol Psychiatry. 2021; 26(1): 41-50.
Goodwin SR, Moskal D, Marks RM, Clark AE, Squeglia LM, Roche DJO. A Scoping Review of Gender, Sex and Sexuality Differences in Polysubstance Use in Adolescents and Adults. Alcohol and Alcoholism. 2022; 57(3): 292-321.
LaGrotta C. Gender Differences in Addiction. Curr Addict Rep. 2021; 8(1): 64-70.
Fogelman N, Tate M, Wemm S, Sullivan L, Hart R, Vacey E, vd. Substance Use Patterns, Quantities, and Associated Risk Factors in Women With Polysubstance Misuse. Addiction Biology. 2024; 29(4): 1-12.
de Angelis C, Nardone A, Garifalos F, Pivonello C, Sansone A, Conforti A, et al. Smoke, Alcohol and Drug Addiction and Female Fertility. Reprod Biol Endocrinol. 2020; 18(1): 21.
Martin CE, Scialli A, Terplan M. Unmet Substance Use Disorder Treatment Need Among Reproductive Age Women. Drug Alcohol Depend. 2020; 206(1): 107679.
Hurley EA, Goggin K, Piña-Brugman K, Noel-MacDonnell JR, Allen A, Finocchario-Kessler S, vd. Contraception Use Among Individuals With Substance Use Disorder Increases Tenfold With Patient-Centered, Mobile Services: a Quasi-Experimental Study. Harm Reduct J. 2023; 20(1): 28.
Rosa-Mangeret F, Benski AC, Golaz A, Zala PZ, Kyokan M, Wagner N, et al. 2.5 Million Annual Deaths-Are Neonates in Low- and Middle-Income Countries Too Small to Be Seen? A Bottom-Up Overview on Neonatal Morbi-Mortality. Trop Med Infect Dis. 2022; 7(5): 64.
The American Collage of Obstetricians and Gynecologists. Prepregnancy Counseling [Internet]. 2019.Erişim adresi: https://www.acog.org/clinical/clinical-guidance/committee-opinion/articles/2019/01/prepregnancy-counseling Erişim tarihi 01.02.2024.
Khekade H, Potdukhe A, Taksande AB, Wanjari MB, Yelne S. Preconception Care: A Strategic Intervention for the Prevention of Neonatal and Birth Disorders. Cureus. 2023; 15(6): e41141.
Schoenaker D, Connolly A, Stephenson J. Preconception Care in Primary Care: Supporting Patients to Have Healthier Pregnancies and Babies. Br J Gen Pract. 2022; 72(717): 152.
Dude AM, Schueler K, Schumm LP, Murugesan M, Stulberg DB. Preconception Care and Severe Maternal Morbidity in the United States. Am J Obstet Gynecol MFM. 2022; 4(2): 100549.
Lee SY, Pearce EN. Preconception Care to Optimize Pregnancy Outcomes. JAMA. 2021; 326(21): 2204-2205.
Cristodoro M, Dell’Avanzo M, Ghio M, Lalatta F, Vena W, Lania A, vd. Before Is Better: Innovative Multidisciplinary Preconception Care in Different Clinical Contexts. J Clin Med. 2023;12(19): 6352.
Bello JK, Salas J, Grucza R. Preconception Health Service Provision Among Women With and Without Substance Use Disorders. Drug Alcohol Depend. 2022; 230(1): 109194.
Ghaemmaghami P, Sarbakhsh F, Janghorban R, Bahrami R. Preconception Care, Prenatal Care, and Postpartum Bonding in Women With Substance Use. Heliyon. 2023; 9(10): e20528.
Thompson EL, Barnett TE, Litt DM, Spears EC, Lewis MA. Discordance Between Perinatal Alcohol Use Among Women and Provider Counseling for Alcohol Use: An Assessment of the Pregnancy Risk Assessment Monitoring System. Public Health Rep. 2021; 136(6): 719-25.
Simmons E, Austin AE. Association of Prenatal Substance Use With Prenatal and Postpartum Care: Evidence From the Pregnancy Risk Assessment Monitoring System, 2016-2019. Prev Med (Baltim). 2022; 159(1): 107065.
Committee Opinion No. 711: Opioid Use and Opioid Use Disorder in Pregnancy. Obstetrics & Gynecology. 2017; 130(2): e81-94.
Lennox R, Patel T, Marmel A, Shaw E. Prenatal Care Outcomes in Women with Substance Use Disorders: A Retrospective Cohort Study. J Obstet Gynaecol Can. 2021; 43(7): 850-855.
Zuberi A, Waqas A, Naveed S, Hossain MM, Rahman A, Saeed K, et al. Prevalence of Mental Disorders in the WHO Eastern Mediterranean Region: A Systematic Review and Meta-Analysis. Front Psychiatry. 2021; 12(14): 665019.
Prewitt KC, Hayer S, Garg B, Benson AE, Hedges MA, Caughey AB, et al. Impact of Prenatal Cannabis Use Disorder on Perinatal Outcomes. J Addict Med. 2022; 17(3): e192-8.
Limburg A, Everett BG, Mollborn S, Kominiarek MA. Sexual Orientation Disparities in Preconception Health. J Womens Health (Larchmt). 2020; 29(6): 755-762.
Hussaini KS, Yocher G. Adverse Maternal Experiences and Neonatal Abstinence Syndrome. Matern Child Health J. 2023; 27(3): 497-507.
Amaje E, Fikrie A, Utura T. Utilization of Preconception Care and Its Associated Factors among Pregnant Women of West Guji Zone, Oromia, Ethiopia, 2021: A Community-Based Cross-Sectional Study. Health Serv Res Manag Epidemiol. 2022; 9(21): 23333928221088720.
Tesema KF, Cheneka T, Alemu A, Feyissa M, Birkaye B, Mohammed H, et al. Knowledge of Preconception Healthcare and Associated Factors: A Study among Mothers in Jinka Town, Southern Region, Ethiopia. Scientific World Journal. 2021;2021:7529805.
World Health Organization. Preconception Care to Reduce Maternal and Childhood Mortality and Morbidity [Internet]. 2013 Erişim adresi: https://www.who.int/publications/i/item/9789241505000 Erişim tarihi: 01.05.2024.
United Nations. Prevalence of Drug Use- Regional and Global Estimates:2021 [Internet]. 2021 Erişim adresi: https://dataunodc.un.org/dp-drug-use-prevalence-regional Erişim tarihi: 01.05.2024.
Avrupa Uyuşturucu ve Uyuşturucu İzleme Merkezi. Avrupa Uyuşturucu Raporu [Internet]. 2022. Erişim adresi: www.emcdda.europa.eu Erişim tarihi: 06.05.2024.
Sağlık Bilgi Sistemleri Genel Müdürlüğü. Sağlık İstatistikleri Yıllığı. [Internet]. 2022. https://dosyasb.saglik.gov.tr/Eklenti/48054/0/siy202205042024pdf.pdf Erişim tarihi: 06.05.2024.
World Health Organization. Global Information System on Alcohol and Health [Internet]. 2022 Erişim adresi: https://www.who.int/news-room/fact-sheets/detail/alcohol Erişim tarihi: 11.05.2024.
Bağımlılıkla Mücadele Yüksek Kurulu. Bireylerin Alkol Kullanma Durumunun Cinsiyet ve Yaş Grubuna Göre Dağılımı 2010-2019 [Internet]. Erişim adresi: https://dosyamerkez.saglik.gov.tr/Eklenti/38503/0/bireylerin-alkol-kullanma-durumunun-cinsiyet-ve-yas-grubuna-gore-dagilimi-2010-2019pdf.pdf Erişim tarihi: 11.05.2024.
Bağımlılıkla Mücadele Yüksek Kurulu. Bireylerin Alkol Kullanmaya Başlama Nedenlerinin Cinsiyete Göre Dağılımı 2010-2019 [Internet]. Erişim adresi: https://dosyamerkez.saglik.gov.tr/Eklenti/38504/0/bireylerin-alkol-kullanmaya-baslama-nedenlerinin-cinsiyete-gore-dagilimi-2010-2019pdf.pdf Erişim tarihi: 11.05.2024.
Türkiye İstatistik Kurumu. Türkiye Sağlık Araştırması, 2022 [Internet]. 2023 Erişim adresi: https://data.tuik.gov.tr/Bulten/Index?p=Turkiye-Saglik-Arastirmasi-2022-49747 Erişim tarihi: 11.05.2024.
World Health Organization. Tobacco. 2023. Erişim adresi: https://www.who.int/news-room/fact-sheets/detail/tobacco Erişim tarihi: 12.05.2024.
Koob GF, Le Moal M. Drug abuse: Hedonic Homeostatic Dysregulation. Science. 1997; 278(5335): 52-58.
Feltenstein MW, See RE, Fuchs RA. Neural Substrates and Circuits of Drug Addiction. Cold Spring Harb Perspect Med. 2021; 11(4): 1-24.
Mollick JA, Kober H. Computational Models of Drug Use and Addiction: A Review. J Abnorm Psychol. 2020; 129(6): 544-555.
Munn-Chernoff MA, Few LR, Matherne CE, Baker JH, Men VY, McCutcheon VV, et al. Eating Disorders İn A Community-Based Sample Of Women With Alcohol Use Disorder And Nicotine Dependence. Drug Alcohol Depend. 2020; 212(1): 107981.
Sharma P, Balhara YPS. Relationship between Substance use and Endocrine Disorders: A Narrative Review. J Psychiat Association Nepal. 2022; 11(1): 37-42.
Ansari NM, Chatur VM, Walode SG. Amenorrhea: a Reviev. World J Pharmaceutical Research. 2022; 11(1): 460-472.
Sujan AC, Alexeeff SE, Slama N, Avalos LA, Adams SR, Conway A, et al. Patterns of Substance Use During Early Pregnancy and Associations With Behavioral Health Characteristics. J Addict Med. 2022; 17(3): e141-7.
Young-Wolff KC, Slama N, Sarovar V, Conway A, Tucker LY, Goler N, et al. Association of Pregnancy Intentions With Substance Use During Early Pregnancy. J Addict Med. 2023; 16(1): 118-121.
Acuff SF, MacKillop J, Murphy JG. A contextualized Reinforcer Pathology Approach to Addiction. Nature Reviews Psychology. 2023; 2(5): 309-323.
Drăgoi AM, Voicu T, Chipeşiu AM, Costea RV. Morphopathological Approaches in Alcoholism. Rom J Morphol Embriyo. 2020; 61(2): 345-351.
Koob GF, Vendruscolo L. Current Topich in Behavioral Neurosciences (1). India: Springer; 2019.
Türkiye Psikiyatri Derneği. Nikotin (Sigara) bağımlılığı [Internet]. Erişim adresi: https://psikiyatri.org.tr/halka-yonelik/46/nikotin-sigara-bagimliligi Erişim tarihi: 10.06.2024.
Nair LR, Liu X. Targeting the α4β2- and α7-Subtypes of Nicotinic Acetylcholine Receptors for Smoking Cessation Medication Development. Author Manuscript. 2019; 10(2): 381.
Bilir N. Sigara ve Beyin (1). Ankara: Klasmat Matbaacılık; 2008. p. 7.
Karakulah K, Sengul C, Sengul C. Sigara Bagimliliginin Genetigi. Psikiyatride Guncel Yaklasimlar - Current Approaches in Psychiatry. 2014; 6(3): 1.
Han B, Compton WM, Jones CM, Einstein EB, Volkow ND. Methamphetamine Use, Methamphetamine Use Disorder, and Associated Overdose Deaths Among US Adults. JAMA Psychiatry. 2021; 78(12): 1329.
Heberle BA, Kluwe-Schiavon B, Bicca C, Melo Rothmann L, Grassi-Oliveira R, Viola TW. Examining Predictors of Cocaine Withdrawal Syndrome at the end of Detoxification Treatment in Women With Cocaine Use Disorder. J Psychiatr Res. 2024; 169(1): 247-256.
Barbosa‐Leiker C, Campbell ANC, McHugh RK, Guille C, Greenfield SF. Opioid Use Disorder in Women and the Implications for Treatment. PRCP. 2021; 3(1): 3-11.
Yeşilay. Alkol Bağımlılığı Nedir? [Internet]. Erişim adresi: https://www.yesilay.org.tr/tr/bagimlilik/alkol-bagimliligi Erişim tarihi: 11.06.2024.
T.C. Sağlık Bakanlığı Sağlık Hizmetleri Genel Müdürlüğü. Madde Bağımlılığı Tanı ve Tedavi Kılavuzu El Kitabı. Akvardar Y, Arıkan Z, Berkmen K, DDilbaz N, OOral G, UUluğ B, vd., editörler. Ankara: T.C. Sağlık Bakanlığı Sağlık Hizmetleri Genel Müdürlüğü; 2012.
Yeşilay. Tütün Bağımlılığı Nedir? [Internet]. Erişim adresi: https://www.yesilay.org.tr/tr/bagimlilik/tutun-bagimliligi?gad_source=1&gclid=CjwKCAjwyJqzBhBaEiwAWDRJVK_yBGo9vMoLaauP4Oq9CI_uxkJtWw7TN87cR63fSh00vsaD8QbKhxoC-3gQAvD_BwE Erişim tarihi: 10.06.2024.
Garey L, Smit T, Clausen BK, Redmond BY, Obasi EM, Businelle MS, et al. Anxiety Sensitivity and Distress Tolerance in Relation to Smoking Abstinence Expectancies Among Black Individuals Who Smoke. J Stud Alcohol Drugs. 2024; 85(2): 244-253.
Kutlu Y. Kadının Madde Kullanımı ve Bağımlılığı Substance Use and Abuse Among Women. Psikiyatri Hemşireliği Dergisi. 2011; 2(2): 90-93.
Nelson LF, Weitzman ER, Levy S. Prevention of Substance Use Disorders. Med Clin North Am. 2022; 106(1): 153-168.
Meng LC, Lin CW, Chuang HM, Chen LK, Hsiao FY. Benzodiazepine Use During Pregnancy and Risk of Miscarriage. JAMA Psychiatry. 2024; 81(4): 366.
Makarious L, Teng A, Oei JL. SIDS is Associated With Prenatal Drug Use: a Meta-Analysis and Systematic Review of 4 238 685 Infants. Arch Dis Child Fetal Neonatal Ed. 2022; 107(6): 617-623.
Gabrhelík R, Mahic M, Lund IO, Bramness J, Selmer R, Skovlund E, et al. Cannabis Use during Pregnancy and Risk of Adverse Birth Outcomes: A Longitudinal Cohort Study. Eur Addict Res. 2021; 27(2): 131-141.
Chang G. Maternal Substance Use: Consequences, Identification, and Interventions. Alcohol Res. 2020; 40(2): 06.
Krans EE, Kim JY, Chen Q, Rothenberger SD, James AE, Kelley D, et al. Outcomes Associated With the Use of Medications for Opioid Use Disorder During Pregnancy. Addiction. 2021; 116(12): 3504-3514.
Qato DM, Zhang C, Gandhi AB, Simoni-Wastila L, Coleman-Cowger VH. Co-use of Alcohol, Tobacco, and Licit and Illicit Controlled Substances Among Pregnant and Non-Pregnant Women in The United States: Findings from 2006 to 2014 National Survey on Drug Use and Health (NSDUH) Data. Drug Alcohol Depend. 2020; 206(1): 107729.
Chang YK, Tseng YT, Chen KT. The Epidemiologic Characteristics and Associated Risk Factors of Preterm Birth From 2004 to 2013 in Taiwan. BMC Pregnancy Childbirth. 2020; 20(1): 201.
Sujan A, Cleary E, Douglas E, Aujla R, Boyars L, Smith C, et al. A Retrospective, Observational Study on Medication for Opioid Use Disorder During Pregnancy and Risk for Neonatal Abstinence Syndrome. Fam Pract. 2022; 39(2): 311-315.
Harris MTH, Laks J, Stahl N, Bagley SM, Saia K, Wechsberg WM. Gender Dynamics in Substance Use and Treatment. Medical Clinics of North America. 2022; 106(1): 219-234.
Harris MTH, Laks J, Hurstak E, Jain JP, Lambert AM, Maschke AD, vd. “If You’re Strung Out and Female, They Will Take Advantage of You”: A Gualitative Study Exploring Drug Use and Substance Use Service Experiences Among Women in Boston and San Francisco. J Subst Use Addict Treat. 2024; 157(1): 209190.
Goldenberg S, Watt S, Braschel M, Hayashi K, Moreheart S, Shannon K. Police-Related Barriers to Harm Reduction Linked to Non-Fatal Overdose Amongst Sex Workers Who Use Drugs: Results of a Community-Based Cohort in Metro Vancouver, Canada. Int J Drug Policy. 2020; 76(1): 102618.
Carter A, Newman C, de Visser R, Yeung A, Rissel C, Grulich A, et al. Unwanted Sex Due to Intoxication among Australians Aged 16–69 Years. J Seks Res. 2021; 58(1): 74-85.
Meyers SA, Smith LR, Werb D. Preventing Transitions Into Injection Drug Use: A Call For Gender-Responsive Upstream Prevention. Int J Drug Policy. 2020; 83(1): 102836.
Popova S, Dozet D, Shield K, Rehm J, Burd L. Alcohol’s Impact on the Fetus. Nutrients. 2021; 13(10): 3452
Sundaram VL, Lamichhane R, Cecchetti A, Arthur S, Murughiyan U. Maternal and Neonatal Outcomes in Women with Metabolic Syndrome and Substance Use Disorder. Life (Basel). 2023;13(9):1933.
Oei JL, Alcohol Use in Pregnancy and Its Impact on The Mother and Child. Addiction. 2020; 115(11): 2148-63.
Havard A, Chandran JJ, Oei JL. Tobacco Use During Pregnancy. Addiction. 2022; 117(6):1801-1810.
Martin CE, Almeida T, Thakkar B, Kimbrough T, Postpartum and Addiction Recovery of Women in Opioid use Disorder Treatment: A Qualitative Study. Subst Abus. 2022; 43(1):389-396.
Hagman BT, Falk D, Litten R, Koob GF, Defining Recovery From Alcohol Use Disorder: Development of an NIAAA Research Definition. Am J Psychiatry. 2022; 179(11): 807-813.
Witkiewitz K, Montes KS, Schwebel FJ, Tucker JA. What Is Recovery? Alcohol Res. 2020; 40(3): 1.
Mellor R, Lancaster K, Ritter A. Recovery From Alcohol Problems in the Absence of Treatment: a Qualitative Narrative Analysis. Addiction. 2021; 116(6): 1413-1423.
DiSilvio B, Baqdunes M, Alhajhusain A, Cheema T, Smoking Addiction and Strategies for Cessation. Crit Care Nurs Q. 2021; 44(1): 33-48.
Johnson MW. Classic Psychedelics in Addiction Treatment: The Case for Psilocybin in Tobacco Smoking Cessation. Curr Top Behav Neurosci. 2022; 56(1): 213-227.
Tutka P, Vinnikov D, Courtney RJ, Benowitz NL. Cytisine for Nicotine Addiction Treatment: a Review of Pharmacology, Therapeutics and an Update of Clinical Trial Evidence for Smoking Cessation. Addiction. 2019; 114(11): 1951-1969.
Nani A, Moreira V, De Oliveira AC, De Castro MC, Vahia P, Rabelo S, vd. Treatment of Smoking Addiction at A Unıversıty Hospital: Immediate and A One Year Follow-Up Results. Chest Congress. 2020; 157(6): 444.
Bradfield Z, Leefhelm E, Soh SE, Black KI, Boyle JA, Kuliukas L, et al. The MidPIC study: Midwives’ Knowledge, Perspectives and Learning Needs Regarding Preconception and Interconception Care. PLoS One. 2023; 18(11): 1-20.
Toquinto SM, Berglas NF, McLemore MR, Delgado A, Roberts SCM. Pregnant Women’s Acceptability of Alcohol, Tobacco, and Drug Use Screening and Willingness to Disclose Use in Prenatal Care. Women’s Health Issues. 2020; 30(5): 345-352.
McGinty EE, Barry CL. Stigma Reduction to Combat the Addiction Crisis - Developing an Evidence Base. N Engl J Med. 2020; 382(14): 1291-1292.
Weber A, Miskle B, Lynch A, Arndt S, Acion L. Substance Use in Pregnancy: Identifying Stigma and Improving Care. Subst Abuse Rehabil. 2021; 12(1): 105-121.
Hughes T, McFadden A, Whittaker A, Boardman JP, Marryat L. Antenatal Care of Women Who Use Opioids: a Qualitative Study of Practitioners’ Perceptions of Strengths and Challenges of Current Service Provision in Scotland. BMC Pregnancy Childbirth. 2024; 24(1): 75.
Stevens MWR, Cooper M, Cusack L, Ali RL, Briley AL. Improving the Quality of Antenatal Screening and Early Intervention For Alcohol and Other Drug Use: Protocol For a Multi-Stage Approach to Systems Reform. Addiction Science & Clinical Practice. 2024; 19(1): 2.
Lukowitsky MR, Balkoski VI, Bromley N, Gallagher PA. The Effects of Screening Brief Intervention Referral to Treatment (SBIRT) training on Health Professional Trainees’ Regard, Attitudes, and Beliefs Toward Patients Who Use Substances. Subst Abus. 2022; 43(1): 397-407.
Smid MC, Terplan M. What Obstetrician–Gynecologists Should Know About Substance Use Disorders in the Perinatal Period. Obstet Gynecol. 2022; 139(2): 317-337.
Chanal C, Mazurier E, Doray B. Use of Psychoactive Substances during the Perinatal Period: Guidelines for Interventions during the Perinatal Period from the French National College of Midwives. J Midwifery Womens Health. 2022; 67(1): 17-37.
Oni HT, Buultjens M, blandthorn J, Davis D, Abdel-latif M, Islam MM. Barriers and Facilitators in Antenatal Settings to Screening and Referral of Pregnant Women Who Use Alcohol or Other Drugs: A Qualitative Study of Midwives’ Experience. Midwifery. 2020; 81(1): 1-8.
Hooks C. Attitudes Toward Substance Misusing Pregnant Women Following a Specialist Education Programme: An Exploratory Case Study. Midwifery. 2019; 76(1): 45-53.
Sezgin D, Aydın Kartal Y. Gebelik Döneminde Kanıta Dayalı Yaklaşımların Güncel Rehberler Doğrultusunda İncelenmesi. Ank Sağ Bil Derg. 2021; 10(1): 92-107.
Rizk AH, Simonsen SE, Roberts L, Taylor‐Swanson L, Lemoine JB, Smid M. Maternity Care for Pregnant Women with Opioid Use Disorder: A Review. J Midwifery Womens Health. 2019; 64(5): 532-44.
Öskan Fırat B, Güngör Satılmış İ. Perinatolojide Özel Gruplar ve Hemşirelik Bakımı. Izmir Democracy University Health Sciences Journal. 2022; 5(3): 664-680.
Geraghty S, Doleman G, De Leo A. Midwives’ Attitudes Towards Pregnant Women Using Substances: Informing a Care Pathway. Women Birth. 2019; 32(4): e477-482.
Crummy EA, O’Neal TJ, Baskin BM, Ferguson SM. One Is Not Enough: Understanding and Modeling Polysubstance Use. Front Neurosci. 2020; 16(14): 569.
U.S. Department of Health and Human Services. Addiction and Substance Misuse Reports and Publications [Internet]. 2023 Erişim adresi: https://www.hhs.gov/surgeongeneral/reports-and-publications/addiction-and-substance-misuse/index.html Erişim tarihi: 02.05.2024.
Vafaie N, Kober H. Association of Drug Cues and Craving With Drug Use and Relapse: A Systematic Review and Meta-analysis. JAMA Psychiatry. 2022; 79(7): 641-650.
Compton WM, Valentino RJ, DuPont RL. Polysubstance use in the U.S. opioid crisis. Mol Psychiatry. 2021; 26(1): 41-50.
Goodwin SR, Moskal D, Marks RM, Clark AE, Squeglia LM, Roche DJO. A Scoping Review of Gender, Sex and Sexuality Differences in Polysubstance Use in Adolescents and Adults. Alcohol and Alcoholism. 2022; 57(3): 292-321.
LaGrotta C. Gender Differences in Addiction. Curr Addict Rep. 2021; 8(1): 64-70.
Fogelman N, Tate M, Wemm S, Sullivan L, Hart R, Vacey E, vd. Substance Use Patterns, Quantities, and Associated Risk Factors in Women With Polysubstance Misuse. Addiction Biology. 2024; 29(4): 1-12.
de Angelis C, Nardone A, Garifalos F, Pivonello C, Sansone A, Conforti A, et al. Smoke, Alcohol and Drug Addiction and Female Fertility. Reprod Biol Endocrinol. 2020; 18(1): 21.
Martin CE, Scialli A, Terplan M. Unmet Substance Use Disorder Treatment Need Among Reproductive Age Women. Drug Alcohol Depend. 2020; 206(1): 107679.
Hurley EA, Goggin K, Piña-Brugman K, Noel-MacDonnell JR, Allen A, Finocchario-Kessler S, vd. Contraception Use Among Individuals With Substance Use Disorder Increases Tenfold With Patient-Centered, Mobile Services: a Quasi-Experimental Study. Harm Reduct J. 2023; 20(1): 28.
Rosa-Mangeret F, Benski AC, Golaz A, Zala PZ, Kyokan M, Wagner N, et al. 2.5 Million Annual Deaths-Are Neonates in Low- and Middle-Income Countries Too Small to Be Seen? A Bottom-Up Overview on Neonatal Morbi-Mortality. Trop Med Infect Dis. 2022; 7(5): 64.
The American Collage of Obstetricians and Gynecologists. Prepregnancy Counseling [Internet]. 2019.Erişim adresi: https://www.acog.org/clinical/clinical-guidance/committee-opinion/articles/2019/01/prepregnancy-counseling Erişim tarihi 01.02.2024.
Khekade H, Potdukhe A, Taksande AB, Wanjari MB, Yelne S. Preconception Care: A Strategic Intervention for the Prevention of Neonatal and Birth Disorders. Cureus. 2023; 15(6): e41141.
Schoenaker D, Connolly A, Stephenson J. Preconception Care in Primary Care: Supporting Patients to Have Healthier Pregnancies and Babies. Br J Gen Pract. 2022; 72(717): 152.
Dude AM, Schueler K, Schumm LP, Murugesan M, Stulberg DB. Preconception Care and Severe Maternal Morbidity in the United States. Am J Obstet Gynecol MFM. 2022; 4(2): 100549.
Lee SY, Pearce EN. Preconception Care to Optimize Pregnancy Outcomes. JAMA. 2021; 326(21): 2204-2205.
Cristodoro M, Dell’Avanzo M, Ghio M, Lalatta F, Vena W, Lania A, vd. Before Is Better: Innovative Multidisciplinary Preconception Care in Different Clinical Contexts. J Clin Med. 2023;12(19): 6352.
Bello JK, Salas J, Grucza R. Preconception Health Service Provision Among Women With and Without Substance Use Disorders. Drug Alcohol Depend. 2022; 230(1): 109194.
Ghaemmaghami P, Sarbakhsh F, Janghorban R, Bahrami R. Preconception Care, Prenatal Care, and Postpartum Bonding in Women With Substance Use. Heliyon. 2023; 9(10): e20528.
Thompson EL, Barnett TE, Litt DM, Spears EC, Lewis MA. Discordance Between Perinatal Alcohol Use Among Women and Provider Counseling for Alcohol Use: An Assessment of the Pregnancy Risk Assessment Monitoring System. Public Health Rep. 2021; 136(6): 719-25.
Simmons E, Austin AE. Association of Prenatal Substance Use With Prenatal and Postpartum Care: Evidence From the Pregnancy Risk Assessment Monitoring System, 2016-2019. Prev Med (Baltim). 2022; 159(1): 107065.
Committee Opinion No. 711: Opioid Use and Opioid Use Disorder in Pregnancy. Obstetrics & Gynecology. 2017; 130(2): e81-94.
Lennox R, Patel T, Marmel A, Shaw E. Prenatal Care Outcomes in Women with Substance Use Disorders: A Retrospective Cohort Study. J Obstet Gynaecol Can. 2021; 43(7): 850-855.
Zuberi A, Waqas A, Naveed S, Hossain MM, Rahman A, Saeed K, et al. Prevalence of Mental Disorders in the WHO Eastern Mediterranean Region: A Systematic Review and Meta-Analysis. Front Psychiatry. 2021; 12(14): 665019.
Prewitt KC, Hayer S, Garg B, Benson AE, Hedges MA, Caughey AB, et al. Impact of Prenatal Cannabis Use Disorder on Perinatal Outcomes. J Addict Med. 2022; 17(3): e192-8.
Limburg A, Everett BG, Mollborn S, Kominiarek MA. Sexual Orientation Disparities in Preconception Health. J Womens Health (Larchmt). 2020; 29(6): 755-762.
Hussaini KS, Yocher G. Adverse Maternal Experiences and Neonatal Abstinence Syndrome. Matern Child Health J. 2023; 27(3): 497-507.
Amaje E, Fikrie A, Utura T. Utilization of Preconception Care and Its Associated Factors among Pregnant Women of West Guji Zone, Oromia, Ethiopia, 2021: A Community-Based Cross-Sectional Study. Health Serv Res Manag Epidemiol. 2022; 9(21): 23333928221088720.
Tesema KF, Cheneka T, Alemu A, Feyissa M, Birkaye B, Mohammed H, et al. Knowledge of Preconception Healthcare and Associated Factors: A Study among Mothers in Jinka Town, Southern Region, Ethiopia. Scientific World Journal. 2021;2021:7529805.
World Health Organization. Preconception Care to Reduce Maternal and Childhood Mortality and Morbidity [Internet]. 2013 Erişim adresi: https://www.who.int/publications/i/item/9789241505000 Erişim tarihi: 01.05.2024.
United Nations. Prevalence of Drug Use- Regional and Global Estimates:2021 [Internet]. 2021 Erişim adresi: https://dataunodc.un.org/dp-drug-use-prevalence-regional Erişim tarihi: 01.05.2024.
Avrupa Uyuşturucu ve Uyuşturucu İzleme Merkezi. Avrupa Uyuşturucu Raporu [Internet]. 2022. Erişim adresi: www.emcdda.europa.eu Erişim tarihi: 06.05.2024.
Sağlık Bilgi Sistemleri Genel Müdürlüğü. Sağlık İstatistikleri Yıllığı. [Internet]. 2022. https://dosyasb.saglik.gov.tr/Eklenti/48054/0/siy202205042024pdf.pdf Erişim tarihi: 06.05.2024.
World Health Organization. Global Information System on Alcohol and Health [Internet]. 2022 Erişim adresi: https://www.who.int/news-room/fact-sheets/detail/alcohol Erişim tarihi: 11.05.2024.
Bağımlılıkla Mücadele Yüksek Kurulu. Bireylerin Alkol Kullanma Durumunun Cinsiyet ve Yaş Grubuna Göre Dağılımı 2010-2019 [Internet]. Erişim adresi: https://dosyamerkez.saglik.gov.tr/Eklenti/38503/0/bireylerin-alkol-kullanma-durumunun-cinsiyet-ve-yas-grubuna-gore-dagilimi-2010-2019pdf.pdf Erişim tarihi: 11.05.2024.
Bağımlılıkla Mücadele Yüksek Kurulu. Bireylerin Alkol Kullanmaya Başlama Nedenlerinin Cinsiyete Göre Dağılımı 2010-2019 [Internet]. Erişim adresi: https://dosyamerkez.saglik.gov.tr/Eklenti/38504/0/bireylerin-alkol-kullanmaya-baslama-nedenlerinin-cinsiyete-gore-dagilimi-2010-2019pdf.pdf Erişim tarihi: 11.05.2024.
Türkiye İstatistik Kurumu. Türkiye Sağlık Araştırması, 2022 [Internet]. 2023 Erişim adresi: https://data.tuik.gov.tr/Bulten/Index?p=Turkiye-Saglik-Arastirmasi-2022-49747 Erişim tarihi: 11.05.2024.
World Health Organization. Tobacco. 2023. Erişim adresi: https://www.who.int/news-room/fact-sheets/detail/tobacco Erişim tarihi: 12.05.2024.
Koob GF, Le Moal M. Drug abuse: Hedonic Homeostatic Dysregulation. Science. 1997; 278(5335): 52-58.
Feltenstein MW, See RE, Fuchs RA. Neural Substrates and Circuits of Drug Addiction. Cold Spring Harb Perspect Med. 2021; 11(4): 1-24.
Mollick JA, Kober H. Computational Models of Drug Use and Addiction: A Review. J Abnorm Psychol. 2020; 129(6): 544-555.
Munn-Chernoff MA, Few LR, Matherne CE, Baker JH, Men VY, McCutcheon VV, et al. Eating Disorders İn A Community-Based Sample Of Women With Alcohol Use Disorder And Nicotine Dependence. Drug Alcohol Depend. 2020; 212(1): 107981.
Sharma P, Balhara YPS. Relationship between Substance use and Endocrine Disorders: A Narrative Review. J Psychiat Association Nepal. 2022; 11(1): 37-42.
Ansari NM, Chatur VM, Walode SG. Amenorrhea: a Reviev. World J Pharmaceutical Research. 2022; 11(1): 460-472.
Sujan AC, Alexeeff SE, Slama N, Avalos LA, Adams SR, Conway A, et al. Patterns of Substance Use During Early Pregnancy and Associations With Behavioral Health Characteristics. J Addict Med. 2022; 17(3): e141-7.
Young-Wolff KC, Slama N, Sarovar V, Conway A, Tucker LY, Goler N, et al. Association of Pregnancy Intentions With Substance Use During Early Pregnancy. J Addict Med. 2023; 16(1): 118-121.
Acuff SF, MacKillop J, Murphy JG. A contextualized Reinforcer Pathology Approach to Addiction. Nature Reviews Psychology. 2023; 2(5): 309-323.
Drăgoi AM, Voicu T, Chipeşiu AM, Costea RV. Morphopathological Approaches in Alcoholism. Rom J Morphol Embriyo. 2020; 61(2): 345-351.
Koob GF, Vendruscolo L. Current Topich in Behavioral Neurosciences (1). India: Springer; 2019.
Türkiye Psikiyatri Derneği. Nikotin (Sigara) bağımlılığı [Internet]. Erişim adresi: https://psikiyatri.org.tr/halka-yonelik/46/nikotin-sigara-bagimliligi Erişim tarihi: 10.06.2024.
Nair LR, Liu X. Targeting the α4β2- and α7-Subtypes of Nicotinic Acetylcholine Receptors for Smoking Cessation Medication Development. Author Manuscript. 2019; 10(2): 381.
Bilir N. Sigara ve Beyin (1). Ankara: Klasmat Matbaacılık; 2008. p. 7.
Karakulah K, Sengul C, Sengul C. Sigara Bagimliliginin Genetigi. Psikiyatride Guncel Yaklasimlar - Current Approaches in Psychiatry. 2014; 6(3): 1.
Han B, Compton WM, Jones CM, Einstein EB, Volkow ND. Methamphetamine Use, Methamphetamine Use Disorder, and Associated Overdose Deaths Among US Adults. JAMA Psychiatry. 2021; 78(12): 1329.
Heberle BA, Kluwe-Schiavon B, Bicca C, Melo Rothmann L, Grassi-Oliveira R, Viola TW. Examining Predictors of Cocaine Withdrawal Syndrome at the end of Detoxification Treatment in Women With Cocaine Use Disorder. J Psychiatr Res. 2024; 169(1): 247-256.
Barbosa‐Leiker C, Campbell ANC, McHugh RK, Guille C, Greenfield SF. Opioid Use Disorder in Women and the Implications for Treatment. PRCP. 2021; 3(1): 3-11.
Yeşilay. Alkol Bağımlılığı Nedir? [Internet]. Erişim adresi: https://www.yesilay.org.tr/tr/bagimlilik/alkol-bagimliligi Erişim tarihi: 11.06.2024.
T.C. Sağlık Bakanlığı Sağlık Hizmetleri Genel Müdürlüğü. Madde Bağımlılığı Tanı ve Tedavi Kılavuzu El Kitabı. Akvardar Y, Arıkan Z, Berkmen K, DDilbaz N, OOral G, UUluğ B, vd., editörler. Ankara: T.C. Sağlık Bakanlığı Sağlık Hizmetleri Genel Müdürlüğü; 2012.
Yeşilay. Tütün Bağımlılığı Nedir? [Internet]. Erişim adresi: https://www.yesilay.org.tr/tr/bagimlilik/tutun-bagimliligi?gad_source=1&gclid=CjwKCAjwyJqzBhBaEiwAWDRJVK_yBGo9vMoLaauP4Oq9CI_uxkJtWw7TN87cR63fSh00vsaD8QbKhxoC-3gQAvD_BwE Erişim tarihi: 10.06.2024.
Garey L, Smit T, Clausen BK, Redmond BY, Obasi EM, Businelle MS, et al. Anxiety Sensitivity and Distress Tolerance in Relation to Smoking Abstinence Expectancies Among Black Individuals Who Smoke. J Stud Alcohol Drugs. 2024; 85(2): 244-253.
Kutlu Y. Kadının Madde Kullanımı ve Bağımlılığı Substance Use and Abuse Among Women. Psikiyatri Hemşireliği Dergisi. 2011; 2(2): 90-93.
Nelson LF, Weitzman ER, Levy S. Prevention of Substance Use Disorders. Med Clin North Am. 2022; 106(1): 153-168.
Meng LC, Lin CW, Chuang HM, Chen LK, Hsiao FY. Benzodiazepine Use During Pregnancy and Risk of Miscarriage. JAMA Psychiatry. 2024; 81(4): 366.
Makarious L, Teng A, Oei JL. SIDS is Associated With Prenatal Drug Use: a Meta-Analysis and Systematic Review of 4 238 685 Infants. Arch Dis Child Fetal Neonatal Ed. 2022; 107(6): 617-623.
Gabrhelík R, Mahic M, Lund IO, Bramness J, Selmer R, Skovlund E, et al. Cannabis Use during Pregnancy and Risk of Adverse Birth Outcomes: A Longitudinal Cohort Study. Eur Addict Res. 2021; 27(2): 131-141.
Chang G. Maternal Substance Use: Consequences, Identification, and Interventions. Alcohol Res. 2020; 40(2): 06.
Krans EE, Kim JY, Chen Q, Rothenberger SD, James AE, Kelley D, et al. Outcomes Associated With the Use of Medications for Opioid Use Disorder During Pregnancy. Addiction. 2021; 116(12): 3504-3514.
Qato DM, Zhang C, Gandhi AB, Simoni-Wastila L, Coleman-Cowger VH. Co-use of Alcohol, Tobacco, and Licit and Illicit Controlled Substances Among Pregnant and Non-Pregnant Women in The United States: Findings from 2006 to 2014 National Survey on Drug Use and Health (NSDUH) Data. Drug Alcohol Depend. 2020; 206(1): 107729.
Chang YK, Tseng YT, Chen KT. The Epidemiologic Characteristics and Associated Risk Factors of Preterm Birth From 2004 to 2013 in Taiwan. BMC Pregnancy Childbirth. 2020; 20(1): 201.
Sujan A, Cleary E, Douglas E, Aujla R, Boyars L, Smith C, et al. A Retrospective, Observational Study on Medication for Opioid Use Disorder During Pregnancy and Risk for Neonatal Abstinence Syndrome. Fam Pract. 2022; 39(2): 311-315.
Harris MTH, Laks J, Stahl N, Bagley SM, Saia K, Wechsberg WM. Gender Dynamics in Substance Use and Treatment. Medical Clinics of North America. 2022; 106(1): 219-234.
Harris MTH, Laks J, Hurstak E, Jain JP, Lambert AM, Maschke AD, vd. “If You’re Strung Out and Female, They Will Take Advantage of You”: A Gualitative Study Exploring Drug Use and Substance Use Service Experiences Among Women in Boston and San Francisco. J Subst Use Addict Treat. 2024; 157(1): 209190.
Goldenberg S, Watt S, Braschel M, Hayashi K, Moreheart S, Shannon K. Police-Related Barriers to Harm Reduction Linked to Non-Fatal Overdose Amongst Sex Workers Who Use Drugs: Results of a Community-Based Cohort in Metro Vancouver, Canada. Int J Drug Policy. 2020; 76(1): 102618.
Carter A, Newman C, de Visser R, Yeung A, Rissel C, Grulich A, et al. Unwanted Sex Due to Intoxication among Australians Aged 16–69 Years. J Seks Res. 2021; 58(1): 74-85.
Meyers SA, Smith LR, Werb D. Preventing Transitions Into Injection Drug Use: A Call For Gender-Responsive Upstream Prevention. Int J Drug Policy. 2020; 83(1): 102836.
Popova S, Dozet D, Shield K, Rehm J, Burd L. Alcohol’s Impact on the Fetus. Nutrients. 2021; 13(10): 3452
Sundaram VL, Lamichhane R, Cecchetti A, Arthur S, Murughiyan U. Maternal and Neonatal Outcomes in Women with Metabolic Syndrome and Substance Use Disorder. Life (Basel). 2023;13(9):1933.
Oei JL, Alcohol Use in Pregnancy and Its Impact on The Mother and Child. Addiction. 2020; 115(11): 2148-63.
Havard A, Chandran JJ, Oei JL. Tobacco Use During Pregnancy. Addiction. 2022; 117(6):1801-1810.
Martin CE, Almeida T, Thakkar B, Kimbrough T, Postpartum and Addiction Recovery of Women in Opioid use Disorder Treatment: A Qualitative Study. Subst Abus. 2022; 43(1):389-396.
Hagman BT, Falk D, Litten R, Koob GF, Defining Recovery From Alcohol Use Disorder: Development of an NIAAA Research Definition. Am J Psychiatry. 2022; 179(11): 807-813.
Witkiewitz K, Montes KS, Schwebel FJ, Tucker JA. What Is Recovery? Alcohol Res. 2020; 40(3): 1.
Mellor R, Lancaster K, Ritter A. Recovery From Alcohol Problems in the Absence of Treatment: a Qualitative Narrative Analysis. Addiction. 2021; 116(6): 1413-1423.
DiSilvio B, Baqdunes M, Alhajhusain A, Cheema T, Smoking Addiction and Strategies for Cessation. Crit Care Nurs Q. 2021; 44(1): 33-48.
Johnson MW. Classic Psychedelics in Addiction Treatment: The Case for Psilocybin in Tobacco Smoking Cessation. Curr Top Behav Neurosci. 2022; 56(1): 213-227.
Tutka P, Vinnikov D, Courtney RJ, Benowitz NL. Cytisine for Nicotine Addiction Treatment: a Review of Pharmacology, Therapeutics and an Update of Clinical Trial Evidence for Smoking Cessation. Addiction. 2019; 114(11): 1951-1969.
Nani A, Moreira V, De Oliveira AC, De Castro MC, Vahia P, Rabelo S, vd. Treatment of Smoking Addiction at A Unıversıty Hospital: Immediate and A One Year Follow-Up Results. Chest Congress. 2020; 157(6): 444.
Bradfield Z, Leefhelm E, Soh SE, Black KI, Boyle JA, Kuliukas L, et al. The MidPIC study: Midwives’ Knowledge, Perspectives and Learning Needs Regarding Preconception and Interconception Care. PLoS One. 2023; 18(11): 1-20.
Toquinto SM, Berglas NF, McLemore MR, Delgado A, Roberts SCM. Pregnant Women’s Acceptability of Alcohol, Tobacco, and Drug Use Screening and Willingness to Disclose Use in Prenatal Care. Women’s Health Issues. 2020; 30(5): 345-352.
McGinty EE, Barry CL. Stigma Reduction to Combat the Addiction Crisis - Developing an Evidence Base. N Engl J Med. 2020; 382(14): 1291-1292.
Weber A, Miskle B, Lynch A, Arndt S, Acion L. Substance Use in Pregnancy: Identifying Stigma and Improving Care. Subst Abuse Rehabil. 2021; 12(1): 105-121.
Hughes T, McFadden A, Whittaker A, Boardman JP, Marryat L. Antenatal Care of Women Who Use Opioids: a Qualitative Study of Practitioners’ Perceptions of Strengths and Challenges of Current Service Provision in Scotland. BMC Pregnancy Childbirth. 2024; 24(1): 75.
Stevens MWR, Cooper M, Cusack L, Ali RL, Briley AL. Improving the Quality of Antenatal Screening and Early Intervention For Alcohol and Other Drug Use: Protocol For a Multi-Stage Approach to Systems Reform. Addiction Science & Clinical Practice. 2024; 19(1): 2.
Lukowitsky MR, Balkoski VI, Bromley N, Gallagher PA. The Effects of Screening Brief Intervention Referral to Treatment (SBIRT) training on Health Professional Trainees’ Regard, Attitudes, and Beliefs Toward Patients Who Use Substances. Subst Abus. 2022; 43(1): 397-407.
Smid MC, Terplan M. What Obstetrician–Gynecologists Should Know About Substance Use Disorders in the Perinatal Period. Obstet Gynecol. 2022; 139(2): 317-337.
Chanal C, Mazurier E, Doray B. Use of Psychoactive Substances during the Perinatal Period: Guidelines for Interventions during the Perinatal Period from the French National College of Midwives. J Midwifery Womens Health. 2022; 67(1): 17-37.
Oni HT, Buultjens M, blandthorn J, Davis D, Abdel-latif M, Islam MM. Barriers and Facilitators in Antenatal Settings to Screening and Referral of Pregnant Women Who Use Alcohol or Other Drugs: A Qualitative Study of Midwives’ Experience. Midwifery. 2020; 81(1): 1-8.
Hooks C. Attitudes Toward Substance Misusing Pregnant Women Following a Specialist Education Programme: An Exploratory Case Study. Midwifery. 2019; 76(1): 45-53.
Sezgin D, Aydın Kartal Y. Gebelik Döneminde Kanıta Dayalı Yaklaşımların Güncel Rehberler Doğrultusunda İncelenmesi. Ank Sağ Bil Derg. 2021; 10(1): 92-107.
Rizk AH, Simonsen SE, Roberts L, Taylor‐Swanson L, Lemoine JB, Smid M. Maternity Care for Pregnant Women with Opioid Use Disorder: A Review. J Midwifery Womens Health. 2019; 64(5): 532-44.
Öskan Fırat B, Güngör Satılmış İ. Perinatolojide Özel Gruplar ve Hemşirelik Bakımı. Izmir Democracy University Health Sciences Journal. 2022; 5(3): 664-680.
Geraghty S, Doleman G, De Leo A. Midwives’ Attitudes Towards Pregnant Women Using Substances: Informing a Care Pathway. Women Birth. 2019; 32(4): e477-482.
Pages
231-244
Published
January 22, 2025
Copyright (c) 2025 Academician Publishing Book Portal
